{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:57:25Z","timestamp":1774263445788,"version":"3.50.1"},"posted":{"date-parts":[[2026,2,19]]},"group-title":"In Review","reference-count":0,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,2,7]]},"abstract":"<title>Abstract<\/title>\n                <p>NF2-related schwannomatosis (NF2-SWN) is a devastating tumor predisposition syndrome marked by multiple schwannomas and substantial morbidity. Vestibular Schwannoma (VS), the hallmark tumor, causes deafness, vertigo and potentially fatal brainstem compression. A subset develops brainstem adhesions, making surgery - the only treatment option \u2013 highly risky in the absence of FDA-approved therapies. During NF2-SWN progression, schwannoma cells migrate from the extracellular matrix (ECM)-rich internal auditory canal to the arachnoid-lined brainstem, yet mechanisms driving this transition remain incompletely defined. We previously demonstrated that adherent schwannoma is associated with elevated matrix metalloproteinase-9 (MMP-9) activity. N-cadherin (N-cad), a key cell-matrix adhesion molecule and regulator of cancer cell migration, has not been studied in NF2-SWN. Integrating RNA sequencing, multiple NF2 schwannoma mouse models and primary human VS cultures, we demonstrate that N-cad is overexpressed in sporadic and NF2-associated VS. N-cad differentially regulates VS spheroid migration \u2013 promoting motility on astrocytes but restraining on ECM. MMP-9 cleaves N-cad to drive schwannoma proliferation through IL-6\/STAT3 and NF-\u03baB signaling. Pharmacologic and genetic inhibition of N-cad synergized with dasatinib and brigatinib, two kinase inhibitors with efficacy in NF2-SWN, to suppress schwannoma proliferation and tumor growth. These findings establish N-cad as a central regulator of schwannoma migration and a novel therapeutic target.<\/p>","DOI":"10.21203\/rs.3.rs-8817797\/v1","type":"posted-content","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:40:26Z","timestamp":1771512026000},"source":"Crossref","is-referenced-by-count":0,"title":["N-Cadherin Dynamically Regulates Schwannoma Migration and Represents a Novel Therapeutic Target in NF2-Related Schwannomatosis"],"prefix":"10.21203","author":[{"given":"Yin","family":"Ren","sequence":"first","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Nguyen","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Fisher","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Jan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8817797\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8817797\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:02:41Z","timestamp":1774260161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8817797\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":0,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8817797\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,2,19]]},"subtype":"preprint"}}